STREPTOMYCIN
Surgical Site Infection
Third Affiliated Hospital, Sun Yat-Sen UniversitySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Surgical Site Infection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
METRONIDAZOLE Helsinki University Central Hospital | Phase 4 | BBB |
MACROGOLS Helsinki University Central Hospital | Phase 4 | BBB |
NEOMYCIN Helsinki University Central Hospital | Phase 4 | BBB |
Activematrix Baylor College of Medicine | Phase 4 | BB |
TOCOPHEROL ACETATE Hospital General Universitario Elche | Phase 3 | BB |
View all 13 →
Same molecule, other indications
STREPTOMYCIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →